Enabling researchers to conduct immunogenicity and pharmacological studies of biotherapeutic candidates
During the development of biological products, comprehensive studies are conducted throughout various stages to evaluate any potential risks and assess their effectiveness.
Preclinical development plays an important role in identifying potential side effects, such as immunotoxicity, that large molecule candidates may pose on the immune system. Additionally, strict regulations are also in place to minimize risks, prioritize safety, and enable the responsible development and approval of biological products.
Our comprehensive suite of tools has been developed to help support researchers in understanding key characteristics of biological drug candidates. This includes tools for investigating immunogenicity, pharmacokinetics (PK), and pharmacodynamics (PD), as well as evaluating the immune system response and in vivo metabolism of biologic drugs.
In addition, our informatics solution empowers researchers with the ability to interpret, assess, and predict potential immunogenicity early in the drug discovery workflow. By providing valuable insights, this solution can help to increase success rates of your biotherapeutic development.
For research use only. Not for use in diagnostic procedures.
